Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Autoantibodies in chronic obstructive pulmonary disease: A systematic review.

Byrne R, Todd I, Tighe PJ, Fairclough LC.

Immunol Lett. 2019 Oct;214:8-15. doi: 10.1016/j.imlet.2019.08.007. Epub 2019 Aug 28. Review.

PMID:
31472176
2.
3.

Cigarette smoking differentially affects immunoglobulin class levels in serum and saliva: An investigation and review.

Tarbiah N, Todd I, Tighe PJ, Fairclough LC.

Basic Clin Pharmacol Toxicol. 2019 Jun 20. doi: 10.1111/bcpt.13278. [Epub ahead of print]

PMID:
31219219
4.

Patients with tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) are hypersensitive to Toll-like receptor 9 stimulation.

Negm OH, Singh S, Abduljabbar W, Hamed MR, Radford P, McDermott EM, Drewe E, Fairclough L, Todd I, Tighe PJ.

Clin Exp Immunol. 2019 Sep;197(3):352-360. doi: 10.1111/cei.13306. Epub 2019 May 22.

PMID:
31009059
5.

Immunological and pathological effects of electronic cigarettes.

Chen IL, Todd I, Fairclough LC.

Basic Clin Pharmacol Toxicol. 2019 Sep;125(3):237-252. doi: 10.1111/bcpt.13225. Epub 2019 May 7. Review.

PMID:
30861614
6.

Additive manufacturing titanium components with isotropic or graded properties by hybrid electron beam melting/hot isostatic pressing powder processing.

Hernández-Nava E, Mahoney P, Smith CJ, Donoghue J, Todd I, Tammas-Williams S.

Sci Rep. 2019 Mar 11;9(1):4070. doi: 10.1038/s41598-019-40722-3.

7.

Publisher Correction: Damage-tolerant architected materials inspired by crystal microstructure.

Pham MS, Liu C, Todd I, Lertthanasarn J.

Nature. 2019 Mar;567(7748):E14. doi: 10.1038/s41586-019-0968-y.

PMID:
30820031
8.

Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity.

Holmes J, Fairclough LC, Todd I.

Arch Dermatol Res. 2019 Apr;311(3):141-162. doi: 10.1007/s00403-019-01890-4. Epub 2019 Feb 23.

PMID:
30798353
9.

Damage-tolerant architected materials inspired by crystal microstructure.

Pham MS, Liu C, Todd I, Lertthanasarn J.

Nature. 2019 Jan;565(7739):305-311. doi: 10.1038/s41586-018-0850-3. Epub 2019 Jan 16. Erratum in: Nature. 2019 Mar;567(7748):E14.

10.

Tobacco smoke and nicotine suppress expression of activating signaling molecules in human dendritic cells.

Alkhattabi N, Todd I, Negm O, Tighe PJ, Fairclough LC.

Toxicol Lett. 2018 Dec 15;299:40-46. doi: 10.1016/j.toxlet.2018.09.002. Epub 2018 Sep 15.

PMID:
30227238
11.

Assessment of patient understanding of their medicines: interviews with community dwelling older Australians.

Corre LJ, Hotham E, Tsimbinos J, Todd I, Scarlett G, Suppiah V.

Int J Pharm Pract. 2018 Dec;26(6):568-572. doi: 10.1111/ijpp.12466. Epub 2018 Jun 29.

PMID:
29956860
12.

Prophylactic Antibiotic Use in COPD and the Potential Anti-Inflammatory Activities of Antibiotics.

Huckle AW, Fairclough LC, Todd I.

Respir Care. 2018 May;63(5):609-619. doi: 10.4187/respcare.05943. Epub 2018 Feb 20. Review.

13.

Metallurgy: Printing steels.

Todd I.

Nat Mater. 2017 Dec 19;17(1):13-14. doi: 10.1038/nmat5042. No abstract available.

PMID:
29255224
14.

IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.

Saniklidou AH, Tighe PJ, Fairclough LC, Todd I.

Arch Dermatol Res. 2018 Jan;310(1):11-28. doi: 10.1007/s00403-017-1789-1. Epub 2017 Oct 25. Review.

15.

Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease.

Shindi R, Almehairi A, Negm OH, Kalsheker N, Gale NS, Shale DJ, Harrison TW, Bolton CE, John M, Todd I, Tighe PJ, Fairclough LC.

Clin Immunol. 2017 Oct;183:344-353. doi: 10.1016/j.clim.2017.09.020. Epub 2017 Sep 23.

PMID:
28951328
16.

Metallurgy: No more tears for metal 3D printing.

Todd I.

Nature. 2017 Sep 20;549(7672):342-343. doi: 10.1038/549342a. No abstract available.

PMID:
28933429
17.

Positive mood on the day of influenza vaccination predicts vaccine effectiveness: A prospective observational cohort study.

Ayling K, Fairclough L, Tighe P, Todd I, Halliday V, Garibaldi J, Royal S, Hamed A, Buchanan H, Vedhara K.

Brain Behav Immun. 2018 Jan;67:314-323. doi: 10.1016/j.bbi.2017.09.008. Epub 2017 Sep 18.

18.

Tailoring the thermal conductivity of the powder bed in Electron Beam Melting (EBM) Additive Manufacturing.

Smith CJ, Tammas-Williams S, Hernandez-Nava E, Todd I.

Sci Rep. 2017 Sep 5;7(1):10514. doi: 10.1038/s41598-017-11243-8.

19.

A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing.

Todd I, Negm OH, Reps J, Radford P, Figueredo G, McDermott EM, Drewe E, Powell RJ, Bainbridge S, Hamed M, Crouch S, Garibaldi J, St-Gallay S, Fairclough LC, Tighe PJ.

Pharmacol Res. 2017 Nov;125(Pt B):188-200. doi: 10.1016/j.phrs.2017.08.012. Epub 2017 Aug 30.

PMID:
28860008
20.

The Influence of Porosity on Fatigue Crack Initiation in Additively Manufactured Titanium Components.

Tammas-Williams S, Withers PJ, Todd I, Prangnell PB.

Sci Rep. 2017 Aug 4;7(1):7308. doi: 10.1038/s41598-017-06504-5.

21.

Atomic structure of Mg-based metallic glasses from molecular dynamics and neutron diffraction.

Gulenko A, Forto Chungong L, Gao J, Todd I, Hannon AC, Martin RA, Christie JK.

Phys Chem Chem Phys. 2017 Mar 22;19(12):8504-8515. doi: 10.1039/c6cp03261c.

22.

The Effect of Electronic Structure on the Phases Present in High Entropy Alloys.

Leong Z, Wróbel JS, Dudarev SL, Goodall R, Todd I, Nguyen-Manh D.

Sci Rep. 2017 Jan 6;7:39803. doi: 10.1038/srep39803.

23.

Peripheral killer cells do not differentiate between asthma patients with or without fixed airway obstruction.

Tubby C, Negm OH, Harrison T, Tighe PJ, Todd I, Fairclough LC.

J Asthma. 2017 Jun;54(5):456-466. doi: 10.1080/02770903.2016.1236941. Epub 2016 Oct 13.

PMID:
27736259
24.

SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells.

Moz S, Basso D, Bozzato D, Galozzi P, Navaglia F, Negm OH, Arrigoni G, Zambon CF, Padoan A, Tighe P, Todd I, Franchin C, Pedrazzoli S, Punzi L, Plebani M.

Oncotarget. 2016 Oct 25;7(43):69927-69944. doi: 10.18632/oncotarget.12068.

25.

The application of protein microarray assays in psychoneuroimmunology.

Ayling K, Bowden T, Tighe P, Todd I, Dilnot EM, Negm OH, Fairclough L, Vedhara K.

Brain Behav Immun. 2017 Jan;59:62-66. doi: 10.1016/j.bbi.2016.09.013. Epub 2016 Sep 14.

PMID:
27640078
26.

Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease.

Selvarajah S, Todd I, Tighe PJ, John M, Bolton CE, Harrison T, Fairclough LC.

Mediators Inflamm. 2016;2016:3604842. doi: 10.1155/2016/3604842. Epub 2016 Jul 25.

27.

Meals on Wheels? A Decade of Megafaunal Visual and Acoustic Observations from Offshore Oil & Gas Rigs and Platforms in the North and Irish Seas.

Todd VL, Warley JC, Todd IB.

PLoS One. 2016 Apr 14;11(4):e0153320. doi: 10.1371/journal.pone.0153320. eCollection 2016.

28.

Modifying Hofstee standard setting for assessments that vary in difficulty, and to determine boundaries for different levels of achievement.

Burr SA, Whittle J, Fairclough LC, Coombes L, Todd I.

BMC Med Educ. 2016 Jan 28;16:34. doi: 10.1186/s12909-016-0555-y.

29.

Mechanical and electrochemical characterisation of new Ti-Mo-Nb-Zr alloys for biomedical applications.

Nnamchi PS, Obayi CS, Todd I, Rainforth MW.

J Mech Behav Biomed Mater. 2016 Jul;60:68-77. doi: 10.1016/j.jmbbm.2015.12.023. Epub 2015 Dec 28.

PMID:
26773649
30.

Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome.

Fairclough LC, Stoop AA, Negm OH, Radford PM, Tighe PJ, Todd I.

Eur J Immunol. 2015 Oct;45(10):2937-44. doi: 10.1002/eji.201545769. Epub 2015 Aug 17.

31.

The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.

Greco E, Aita A, Galozzi P, Gava A, Sfriso P, Negm OH, Tighe P, Caso F, Navaglia F, Dazzo E, De Bortoli M, Rampazzo A, Obici L, Donadei S, Merlini G, Plebani M, Todd I, Basso D, Punzi L.

Arthritis Res Ther. 2015 Apr 3;17:93. doi: 10.1186/s13075-015-0604-7.

32.

Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome.

Galozzi P, Negm O, Greco E, Alkhattabi N, Gava A, Sfriso P, Fairclough L, Todd I, Tighe P, Punzi L.

Reumatismo. 2015 Mar 31;66(4):277-84. doi: 10.4081/reumatismo.2014.772.

33.

ELISA in the multiplex era: potentials and pitfalls.

Tighe PJ, Ryder RR, Todd I, Fairclough LC.

Proteomics Clin Appl. 2015 Apr;9(3-4):406-22. doi: 10.1002/prca.201400130. Epub 2015 Mar 25. Review.

34.

Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease.

Daffa NI, Tighe PJ, Corne JM, Fairclough LC, Todd I.

Clin Exp Immunol. 2015 Apr;180(1):155-63. doi: 10.1111/cei.12565.

35.

Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera.

Selvarajah S, Negm OH, Hamed MR, Tubby C, Todd I, Tighe PJ, Harrison T, Fairclough LC.

Mediators Inflamm. 2014;2014:820304. doi: 10.1155/2014/820304. Epub 2014 Oct 14.

36.

A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).

Negm OH, Mannsperger HA, McDermott EM, Drewe E, Powell RJ, Todd I, Fairclough LC, Tighe PJ.

Eur J Immunol. 2014 Jul;44(7):2096-110. doi: 10.1002/eji.201344328. Epub 2014 Jun 10.

37.

Modifying the Hofstee method may overcome problems.

Todd I, Burr S, Whittle J, Fairclough L.

Med Teach. 2014 Apr;36(4):358-9. doi: 10.3109/0142159X.2014.887842. Epub 2014 Feb 18. No abstract available.

PMID:
24548113
38.

Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Wang J, Urbanowicz RA, Tighe PJ, Todd I, Corne JM, Fairclough LC.

PLoS One. 2013;8(3):e58556. doi: 10.1371/journal.pone.0058556. Epub 2013 Mar 11.

39.

Utility, reliability and reproducibility of immunoassay multiplex kits.

Tighe P, Negm O, Todd I, Fairclough L.

Methods. 2013 May 15;61(1):23-9. doi: 10.1016/j.ymeth.2013.01.003. Epub 2013 Jan 16.

PMID:
23333412
40.

Formation of microporous NiTi by transient liquid phase sintering of elemental powders.

Ismail MH, Goodall R, Davies HA, Todd I.

Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1480-5. doi: 10.1016/j.msec.2012.04.028. Epub 2012 Apr 24.

PMID:
24364948
41.

A feasibility study to investigate the clinical application of functional electrical stimulation (FES), for dropped foot, during the sub-acute phase of stroke - A randomized controlled trial.

Salisbury L, Shiels J, Todd I, Dennis M.

Physiother Theory Pract. 2013 Jan;29(1):31-40. doi: 10.3109/09593985.2012.674087. Epub 2012 Apr 23.

42.

Immunological basis of reversible and fixed airways disease.

Tubby C, Harrison T, Todd I, Fairclough L.

Clin Sci (Lond). 2011 Oct;121(7):285-96. doi: 10.1042/CS20110062. Review.

PMID:
21651498
43.
44.

Functional consequences of disease-associated mutations in TNFR1 elucidated by transcriptome analysis.

Rebelo SL, Radford PM, Bainbridge SE, Todd I, Tighe PJ.

Adv Exp Med Biol. 2011;691:461-70. doi: 10.1007/978-1-4419-6612-4_47. Review. No abstract available.

PMID:
21153350
45.

Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.

Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC.

Respir Res. 2010 Jun 11;11:76. doi: 10.1186/1465-9921-11-76.

46.

Altered effector function of peripheral cytotoxic cells in COPD.

Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC.

Respir Res. 2009 Jun 22;10:53. doi: 10.1186/1465-9921-10-53.

47.

Depression and anxiety symptoms after lower limb amputation: the rise and fall.

Singh R, Ripley D, Pentland B, Todd I, Hunter J, Hutton L, Philip A.

Clin Rehabil. 2009 Mar;23(3):281-6. doi: 10.1177/0269215508094710.

PMID:
19218302
48.

Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.

Rebelo SL, Amel-Kashipaz MR, Radford PM, Bainbridge SE, Fiets R, Fang J, McDermott EM, Powell RJ, Todd I, Tighe PJ.

Arthritis Rheum. 2009 Jan;60(1):269-80. doi: 10.1002/art.24147.

49.

Cell surface expression of TNFRI in tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Nedjai et al.

Todd I, Tighe P, Rebelo S, Powell R.

Arthritis Rheum. 2008 Jul;58(7):2213-4; author reply 2214-5. doi: 10.1002/art.23551. No abstract available.

50.

Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome.

Todd I, Radford PM, Ziegler-Heitbrock L, Ghaemmaghami AM, Powell RJ, Tighe PJ.

Arthritis Rheum. 2007 Dec;56(12):4182-8.

Supplemental Content

Support Center